Literature DB >> 2277

The binding of reduced nicotinamide adenine dinucleotide to citrate synthase of Escherichia coli K12.

H W Duckworth, E K Tong.   

Abstract

Citrate synthase from Escherichia coli enhances the fluorescence of its allosteric inhibitor, NADH, and shifts the peak of emission of the coenzyme from 457 to 428 nm. These effects have been used to measure the binding of NADH to this enzyme under various conditions. The dissociation constant for the NADH-citrate synthase complex is about 0.28 muM at pH 6.2, but increases toward alkaline pH as if binding depends on protonation of a group with a pKa of about 7.05. Over the pH range 6.2-8.7, the number of binding sites decreases from about 0.65 to about 0.25 per citrate synthase subunit. The midpoint of this transition is at about pH 7.7, and it may be one reflection of the partial depolymerization of the enzyme which is known to occur in this pH range. A gel filtration method has been used to verify that the fluorescence enhancement technique accurately reveals all of the NADH molecules bound to the enzyme in the concentration range of interest. NAD+ and NADP+ were weak competitive inhibitors of NADH binding at pH 7.8 (Ki values greater than 1 mM), but stronger inhibition was shown by 5'-AMP and 3'-AMP, with Ki values of 83 +/- 5 and 65 +/- 4 muM, respectively. Acetyl-CoA, one of the substrates, and KCl, an activator, also inhibit the binding in a weakly cooperative manner. All of these effects are consistent with kinetic observations on this system. We interpret our results in terms of two types of binding site for nucleotides on citrate synthase: an active site which binds acetyl-CoA, the substrate, or its analogue 3'-AMP; and an allosteric site which binds NADH or its analogue 5'-AMP and has a lesser affinity for other nicotinamide adenine dinucloetides. When the active site is occupied, we propose that NADH cannot bind to the allosteric site, but 5'-AMP can; conversely, when NADH is the in the allosteric site, the active site cannot be occupied. In addition to these two classes of sites, there must be points for interaction with KCl and other salts. Oxaloacetate, the second substrate, and alpha-ketoglutarate, an inhibitor whose mode of action is believed to be allosteric, have no effect on NADH binding to citrate synthase at pH 7.8. When NADH is bound to citrate synthase, it quenches the intrinsic tryptophan fluorescence of the enzyme. The amount of quenching is proportional to the amount of NADH bound, at least up to a binding ratio of 0.50 NADH per enzyme subunit. This amount of binding leads to the quenching of 53 +/- 5% of the enzyme fluorescence, which means that one NADH molecule can quench all the intrinsic fluorescence of the subunit to which it binds.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 2277     DOI: 10.1021/bi00646a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

Review 1.  Evaluating Cell Metabolism Through Autofluorescence Imaging of NAD(P)H and FAD.

Authors:  Olivia I Kolenc; Kyle P Quinn
Journal:  Antioxid Redox Signal       Date:  2018-01-30       Impact factor: 8.401

2.  Mitochondrial NADH fluorescence is enhanced by complex I binding.

Authors:  Ksenia Blinova; Rodney L Levine; Emily S Boja; Gary L Griffiths; Zhen-Dan Shi; Brian Ruddy; Robert S Balaban
Journal:  Biochemistry       Date:  2008-08-15       Impact factor: 3.162

3.  Fine-tuning citrate synthase flux potentiates and refines metabolic innovation in the Lenski evolution experiment.

Authors:  Erik M Quandt; Jimmy Gollihar; Zachary D Blount; Andrew D Ellington; George Georgiou; Jeffrey E Barrick
Journal:  Elife       Date:  2015-10-14       Impact factor: 8.140

4.  A dual-function RNA balances carbon uptake and central metabolism in Vibrio cholerae.

Authors:  Kavyaa Venkat; Mona Hoyos; James Rj Haycocks; Liam Cassidy; Beatrice Engelmann; Ulrike Rolle-Kampczyk; Martin von Bergen; Andreas Tholey; David C Grainger; Kai Papenfort
Journal:  EMBO J       Date:  2021-10-06       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.